News
ASMB
14.64
-1.61%
-0.24
Weekly Report: what happened at ASMB last week (0715-0719)?
Weekly Report · 3d ago
Weekly Report: what happened at ASMB last week (0708-0712)?
Weekly Report · 07/15 09:06
Insiders Buying American Software And 2 Other Stocks
U.S. Stocks closed mixed on Monday. There were a few notable insider trades. American Software, Inc. And Tile Shop Holdings, Inc made notable insider purchases. Insider purchases indicate confidence in the company’s prospects or that they view the stock as a bargain.
Benzinga · 07/09 11:26
Weekly Report: what happened at ASMB last week (0701-0705)?
Weekly Report · 07/08 09:07
Weekly Report: what happened at ASMB last week (0624-0628)?
Weekly Report · 07/01 09:07
Weekly Report: what happened at ASMB last week (0617-0621)?
Weekly Report · 06/24 09:07
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
TipRanks · 06/20 10:38
HC Wainwright & Co. Reiterates Neutral on Assembly Biosciences
Benzinga · 06/20 10:33
ASSEMBLY BIOSCIENCES DOSES FIRST PARTICIPANT IN PHASE 1B CLINICAL TRIAL EVALUATING NEXT-GENERATION CAPSID ASSEMBLY MODULATOR CANDIDATE ABI-4334 FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION
Reuters · 06/18 12:00
Assembly Biosciences closes $12.6M in equity financings
Healthcare Assembly Biosciences closes $12.6M in equity financings. The sale of common stock to Gilead Sciences maintains 19.9% of voting stock of Assembly Bio. The company's stock is up 2.7% in the last 12 months.
Seeking Alpha · 06/17 13:07
*Assembly Biosciences: Portfolio Includes Four Candidates in Clinical Development >ASMB
Dow Jones · 06/17 12:04
*Assembly Biosciences: Financing Extends Cash Runway Into 1Q 2026 >ASMB
Dow Jones · 06/17 12:04
ASSEMBLY BIOSCIENCES ANNOUNCES $12.6 MILLION IN EQUITY FINANCINGS
Reuters · 06/17 12:03
ASSEMBLY BIOSCIENCES: FUNDING SUPPORTS ADVANCEMENT OF ANTIVIRAL PORTFOLIO, AND EXTENDS CASH RUNWAY INTO Q1 2026
Reuters · 06/17 12:03
*Assembly Biosciences Announces $12.6M in Equity Financing >ASMB
Dow Jones · 06/17 12:03
*Assembly Biosciences: Funding Supports Advancement of Antiviral Portfolio >ASMB
Dow Jones · 06/17 12:03
Assembly Biosciences Announces $12.6M In Equity Financings For The Issuance Of 634,500 Shares Of Its Common Stock And Warrants To Armistice Capital LLC
Assembly Biosciences, Inc. Has raised $12.6 million in separate equity financings. Funding supports advancement of antiviral portfolio, including four candidates in clinical development. Company is developing innovative therapeutics targeting serious viral diseases. The company expects to have cash runway into Q1 2026.
Benzinga · 06/17 12:02
Weekly Report: what happened at ASMB last week (0610-0614)?
Weekly Report · 06/17 09:07
HC Wainwright & Co. Reiterates Neutral on Assembly Biosciences
Benzinga · 06/13 10:33
H.C. Wainwright Sticks to Their Hold Rating for Assembly Biosciences (ASMB)
TipRanks · 06/13 10:17
More
Webull provides a variety of real-time ASMB stock news. You can receive the latest news about Assembly Bioscie through multiple platforms. This information may help you make smarter investment decisions.
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small molecule antiviral therapeutics. The Company’s pipeline includes two helicase-primase inhibitors (HPI) targeting recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, a clinical-stage capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points with the aim of achieving finite treatment and functional cures and research programs focused on the discovery of therapeutics to treat devastating viral diseases, including a non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses and a small molecule interferon-α (IFN-α) receptor (IFNAR) agonist targeting HBV and HDV. HPIs are antiviral agents in development for HSV-1 and HSV-2, with a clinically validated mechanism of action. Its HBV, HSV-1, and HSV-2 programs include ABI-6250, ABI-5366, and ABI-1179.